A high-sensitivity ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine

AbstractThe continuing emergence of designer drugs imposes high demands on the scope and sensitivity of toxicological drug screening procedures. An ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method was developed for screening and simultaneous confirmation of both designer drugs and other drugs of abuse in urine samples in a single run. The method covered selected synthetic cannabinoids and cathinones, amphetamines, natural cannabinoids, opioids, cocaine and other important drugs of abuse, together with their main urinary metabolites. The database consisted of 277 compounds with molecular formula and exact monoisotopic mass; retention time was included for 192 compounds, and primary and secondary qualifier ion exact mass for 191 and 95 compounds, respectively. Following a solid-phase extraction, separation was performed by UHPLC and mass analysis by HR-TOFMS. MS, and broad-band collision-induced dissociation data were acquired at m/z range 50–700. Compound identification was based on a reverse database search with acceptance criteria for retention time, precursor ion mass accuracy, isotopic pattern and abundance of qualifier ions. Mass resolving power in spiked urine samples was on average FWHM 23,500 and mass accuracy 0.3 mDa. The mean and median cut-off concentrations determined for 75 compounds were 4.2 and 1 ng/mL, respectively. The range of cut-off concentrations for synthetic cannabinoids was 0.2–60 ng/mL and for cathinones 0.7–15 ng/mL. The method proved to combine high sensitivity and a wide scope in a manner not previously reported in drugs of abuse screening. The method’s feasibility was demonstrated with 50 authentic urine samples. FigureExtracted ion chromatograms of metabolites of synthetic cannabinoids and their fragments, including a new common metabolite: JWH-072-propanoic acid

[1]  Ilkka Ojanperä,et al.  Combined drug screening and confirmation by liquid chromatography time-of-flight mass spectrometry with reverse database search , 2012, Analytical and Bioanalytical Chemistry.

[2]  Volker Auwärter,et al.  Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction. , 2012, Journal of mass spectrometry : JMS.

[3]  Volker Auwärter,et al.  Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  Ilkka Ojanperä,et al.  Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control , 2012, Analytical and Bioanalytical Chemistry.

[5]  Aldo Polettini,et al.  Rapid and robust confirmation and quantification of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in urine by column switching LC-MS-MS analysis. , 2012, Journal of mass spectrometry : JMS.

[6]  Randall C. Baselt,et al.  Disposition of toxic drugs and chemicals in man , 1982 .

[7]  D. Gerostamoulos,et al.  Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids. , 2012, Journal of analytical toxicology.

[8]  E. Vuori,et al.  Analysis of street drugs in seized material without primary reference standards. , 2004, Analytical chemistry.

[9]  T. Villén,et al.  Evaluation of a direct high-capacity target screening approach for urine drug testing using liquid chromatography-time-of-flight mass spectrometry. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  M. Meyer,et al.  Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept , 2011, Analytical and bioanalytical chemistry.

[11]  J. A. Levisky,et al.  Structure elucidation and identification of a common metabolite for naphthoylindole-based synthetic cannabinoids using LC-TOF and comparison to a synthetic reference standard. , 2013, Forensic science international.

[12]  Matt Anderson,et al.  European Monitoring Centre for Drugs and Drug Addiction , 2014 .

[13]  B. Matuszewski,et al.  Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. , 2003, Analytical chemistry.

[14]  Anna T. Kelly,et al.  Validation of LC-TOF-MS screening for drugs, metabolites, and collateral compounds in forensic toxicology specimens. , 2013, Journal of analytical toxicology.

[15]  C. Moore,et al.  Synthetic cannabinoids in oral fluid. , 2011, Journal of analytical toxicology.

[16]  G. Hynd,et al.  Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists. , 2005, Bioorganic & medicinal chemistry.

[17]  M. Meyer,et al.  2-Methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC-MS and LC-(HR)-MS techniques , 2013, Analytical and Bioanalytical Chemistry.

[18]  Jerry Zweigenbaum,et al.  Development and practical application of a library of CID accurate mass spectra of more than 2,500 toxic compounds for systematic toxicological analysis by LC–QTOF-MS with data-dependent acquisition , 2011, Analytical and bioanalytical chemistry.

[19]  Ralf Zimmermann,et al.  Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. , 2011, Journal of mass spectrometry : JMS.

[20]  P. J. Lai,et al.  Development of a broad toxicological screening technique for urine using ultra-performance liquid chromatography and time-of-flight mass spectrometry. , 2009, Analytica chimica acta.

[21]  M. Thevis,et al.  Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. , 2011, Drug testing and analysis.

[22]  A. Polettini,et al.  Screening for pharmaco-toxicologically relevant compounds in biosamples using high-resolution mass spectrometry: a 'metabolomic' approach to the discrimination between isomers. , 2010, Journal of mass spectrometry : JMS.

[23]  C. Davidson.  New psychoactive substances , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[24]  Grigory Rodchenkov,et al.  Detection of JWH-018 metabolites in smoking mixture post-administration urine. , 2010, Forensic science international.

[25]  E. Vuori,et al.  Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/time-of-flight mass spectrometry. , 2006, Rapid communications in mass spectrometry : RCM.

[26]  V. Auwärter,et al.  LC/ESI-MS/MS method for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windows , 2013, Analytical and Bioanalytical Chemistry.

[27]  V. Auwärter,et al.  Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. , 2013, Addiction.

[28]  V. Shevyrin,et al.  Identification and analytical properties of new synthetic cannabimimetics bearing 2,2,3,3-tetramethylcyclopropanecarbonyl moiety. , 2013, Forensic Science International.

[29]  E. Castrignanò,et al.  Ultra high performance liquid chromatography-electrospray ionization-tandem mass spectrometry screening method for direct analysis of designer drugs, "spice" and stimulants in oral fluid. , 2012, Journal of chromatography. A.

[30]  James B. Kramer,et al.  Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. , 2011, Analytical chemistry.

[31]  V. Auwärter,et al.  Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques. , 2012, Journal of mass spectrometry : JMS.

[32]  M. Meyer,et al.  Development of the first metabolite-based LC-MSn urine drug screening procedure-exemplified for antidepressants , 2011, Analytical and bioanalytical chemistry.

[33]  A. Salomone,et al.  Simultaneous analysis of several synthetic cannabinoids, THC, CBD and CBN, in hair by ultra-high performance liquid chromatography tandem mass spectrometry. Method validation and application to real samples. , 2012, Journal of mass spectrometry : JMS.

[34]  V. Auwärter,et al.  Analysis of 30 synthetic cannabinoids in oral fluid using liquid chromatography-electrospray ionization tandem mass spectrometry. , 2013, Drug testing and analysis.

[35]  E. Vuori,et al.  Toxicological screening of urine for drugs by liquid chromatography/time-of-flight mass spectrometry with automated target library search based on elemental formulas. , 2001, Rapid communications in mass spectrometry : RCM.

[36]  J. Warner,et al.  LC-MS/MS method for the quantitation of metabolites of eight commonly-used synthetic cannabinoids in human urine--an Australian perspective. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[37]  D. Favretto,et al.  New challenges and innovation in forensic toxicology: focus on the "New Psychoactive Substances". , 2013, Journal of chromatography. A.

[38]  T. Rothämel,et al.  Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[39]  J. Nittler,et al.  A Review of “Bath Salts”: Evolving Designer Drugs of Abuse , 2015 .

[40]  Ilkka Ojanperä,et al.  Differentiation of structural isomers in a target drug database by LC/Q-TOFMS using fragmentation prediction. , 2010, Drug testing and analysis.

[41]  Andrea D Fass,et al.  Synthetic Cathinones (Bath Salts): Legal Status and Patterns of Abuse , 2012, The Annals of pharmacotherapy.